July 2021
1. MARBACH JA, Chweich H, Miyashita S, Kapur NK, et al
   Temporary mechanical circulatory support devices: updates from recent studies.
   Curr Opin Cardiol. 2021;36:375-383.
   

   >> Share

   
   May 2021
2. MILLER T, Carter SV, Smith BA
   Disparities in acute decompensated heart failure.
   Curr Opin Cardiol. 2021;36:335-339.
   

   >> Share

   
   March 2021
3. SERVITO T, Elbatarny M, Yanagawa B, Dokollari A, et al
   Surgical repair of ischemic mitral regurgitation: one ring does not fit all.
   Curr Opin Cardiol. 2021;36:154-162.
   

   >> Share

   
   November 2020
4. PAQUIN A, Poirier P, Beaudoin J, Piche ME, et al
   Secondary prevention after CABG: do new agents change the paradigm?
   Curr Opin Cardiol. 2020;35:664-672.
   

   >> Share

   
   
5. WEISS AJ, Svensson LG, Bakaeen FG
   Temporal improvements in perioperative stroke rates following coronary artery bypass grafting.
   Curr Opin Cardiol. 2020;35:679-686.
   

   >> Share

   
   
6. MADHAVAN MV, Stone GW
   Adverse events beyond 1 year after percutaneous coronary intervention.
   Curr Opin Cardiol. 2020;35:687-696.
   

   >> Share

   
   
7. PU Z, Hakim D, Croce K, Stone PH, et al
   Preemptive percutaneous coronary intervention for coronary artery disease: identification of the appropriate high-risk lesion.
   Curr Opin Cardiol. 2020;35:712-719.
   

   >> Share

   
   
8. SINHA A, Rahman H, Perera D
   Ischaemia without obstructive coronary artery disease: the pathophysiology of microvascular dysfunction.
   Curr Opin Cardiol. 2020;35:720-725.
   

   >> Share

   
   
9. BUITEN RA, Zocca P, von Birgelen C
   Thin, very thin, or ultrathin-strut biodegradable or durable polymer-coated drug-eluting stents.
   Curr Opin Cardiol. 2020;35:705-711.
   

   >> Share

   
   
10. MCKIERNAN M, Halkos ME
    Hybrid coronary revascularization: are we there yet?
    Curr Opin Cardiol. 2020;35:673-678.
    

    >> Share

    
    September 2020
11. GUO MH, Nantsios A, Ruel M
    Appropriate therapy for patients with stable ischemic heart disease: a review of literature and the implication of the International Study of Comparative Effectiveness with Medical and Invasive Approaches trial.
    Curr Opin Cardiol. 2020 Sep 15. doi: 10.1097/HCO.0000000000000785.
    

    >> Share

    
    
12. ELBATARNY M, Cheema AN, Mazine A, Verma S, et al
    Revascularization strategies for left main coronary artery disease: current perspectives.
    Curr Opin Cardiol. 2020;35:548-558.
    

    >> Share

    
    
13. GE Y, Deva DP, Connelly KA, Yan AT, et al
    Stress cardiac MRI in stable coronary artery disease.
    Curr Opin Cardiol. 2020;35:566-573.
    

    >> Share

    
    
14. WASSEF AWA, Liu S, Yanagawa B, Verma S, et al
    Percutaneous management of coronary bifurcation lesions: current perspective.
    Curr Opin Cardiol. 2020;35:574-582.
    

    >> Share

    
    
15. KAPOOR K, Cainzos-Achirica M, Nasir K
    The evolving role of coronary artery calcium in preventive cardiology 30 years after the Agatston score.
    Curr Opin Cardiol. 2020;35:500-507.
    

    >> Share

    
    
16. PRABHAKAR M, Liu S, Bagai A, Yanagawa B, et al
    Assessment and management of coronary artery disease in patients undergoing transcatheter aortic valve replacement.
    Curr Opin Cardiol. 2020;35:540-547.
    

    >> Share

    
    
17. EIKELBOOM R, Muller Moran HR, Lodewyks C, Yan W, et al
    The COMPASS trial: practical considerations for application after coronary artery bypass surgery.
    Curr Opin Cardiol. 2020;35:583-588.
    

    >> Share

    
    
18. EL-ANDARI R, Bozso SJ, Kang J, Nagendran J, et al
    A comparison of surgical, total percutaneous, and hybrid approaches to treatment of combined coronary artery and valvular heart disease.
    Curr Opin Cardiol. 2020;35:559-565.
    

    >> Share

    
    August 2020
19. OPOLSKI MP
    Mechanisms of myocardial infarction with nonobstructive coronary atherosclerosis: a multifaceted play of different actors with guarded prognosis.
    Curr Opin Cardiol. 2020 Aug 26. doi: 10.1097/HCO.0000000000000787.
    

    >> Share

    
    July 2020
20. WU WY, Berman AN, Biery DW, Blankstein R, et al
    Recent trends in acute myocardial infarction among the young.
    Curr Opin Cardiol. 2020 Jul 16. doi: 10.1097/HCO.0000000000000781.
    

    >> Share

    
    
21. WHITEHEAD E, Thayer K, Kapur NK
    Clinical trials of acute mechanical circulatory support in cardiogenic shock and high-risk percutaneous coronary intervention.
    Curr Opin Cardiol. 2020;35:332-340.
    

    >> Share

    
    
22. GALOUGAHI KK, Petrossian G, Stone GW, Ali ZA, et al
    The year in review: advances in interventional cardiology in 2019.
    Curr Opin Cardiol. 2020;35:325-331.
    

    >> Share

    
    
23. PARASKEVAS KI, Geroulakos G, Veith FJ, Mikhailidis DP, et al
    Multifocal arterial disease: clinical implications and management.
    Curr Opin Cardiol. 2020;35:412-416.
    

    >> Share

    
    March 2020
24. FROST A, Haddad H, Shavadia J
    Mechanical circulatory support in cardiogenic shock.
    Curr Opin Cardiol. 2020;35:145-149.
    

    >> Share

    
    September 2019
25. YANAGAWA B, Lee J, Puskas JD, Verma S, et al
    Revascularization in left ventricular dysfunction: an update.
    Curr Opin Cardiol. 2019;34:536-542.
    

    >> Share

    
    
26. AL-SABEQ B, Nabi F, Shah DJ
    Assessment of myocardial viability by cardiac MRI.
    Curr Opin Cardiol. 2019;34:502-509.
    

    >> Share

    
    
27. KHALAF S, Chamsi-Pasha M, Al-Mallah MH
    Assessment of myocardial viability by PET.
    Curr Opin Cardiol. 2019;34:466-472.
    

    >> Share

    
    
28. PRADHAN J, Senior R
    Assessment of myocardial viability by myocardial contrast echocardiography: current perspectives.
    Curr Opin Cardiol. 2019;34:495-501.
    

    >> Share

    
    
29. BERMAN AN, Blankstein R
    Current and future role of lipoprotein(a) in preventive cardiology.
    Curr Opin Cardiol. 2019;34:514-518.
    

    >> Share

    
    
30. KHEMKA A, Sawada SG
    Dobutamine echocardiography for assessment of viability in the current era.
    Curr Opin Cardiol. 2019;34:484-489.
    

    >> Share

    
    
31. BOCK A, Estep JD
    Myocardial viability: heart failure perspective.
    Curr Opin Cardiol. 2019;34:459-465.
    

    >> Share

    
    
32. SPADACCIO C, Fremes SE, Gaudino MFL
    Right internal thoracic or radial artery as the second arterial conduit for coronary artery bypass surgery.
    Curr Opin Cardiol. 2019;34:564-570.
    

    >> Share

    
    
33. MALHOTRA S, Gomez J, Doukky R
    Assessment of myocardial viability using single-photon emission computed tomography myocardial perfusion imaging.
    Curr Opin Cardiol. 2019;34:473-483.
    

    >> Share

    
    
34. VERMA S, Sharma A, Kanumilli N, Butler J, et al
    Predictors of heart failure development in type 2 diabetes: a practical approach.
    Curr Opin Cardiol. 2019;34:578-583.
    

    >> Share

    
    
35. RAJA SG
    Total arterial off-pump coronary revascularization: The Holy Grail?
    Curr Opin Cardiol. 2019;34:552-556.
    

    >> Share

    
    August 2019
36. SILVAIN J, Kerneis M, Guerin M, Montalescot G, et al
    Modulation of cholesterol efflux capacity in patients with myocardial infarction.
    Curr Opin Cardiol. 2019 Aug 28. doi: 10.1097/HCO.0000000000000677.
    

    >> Share

    
    July 2019
37. PATEL A, Marah N, Balan P
    Major trials in coronary intervention from 2018.
    Curr Opin Cardiol. 2019;34:323-328.
    

    >> Share

    
    June 2019
38. LIU S, Tsang M, Abdel-Qadir H, Yanagawa B, et al
    Percutaneous coronary intervention for the management of stable ischemic heart disease.
    Curr Opin Cardiol. 2019 Jun 24. doi: 10.1097/HCO.0000000000000655.
    

    >> Share

    
    August 2018
39. KASARGOD PRABHAKAR CR, Stewart R
    Physical activity and mortality in patients with stable coronary heart disease.
    Curr Opin Cardiol. 2018 Aug 22. doi: 10.1097/HCO.0000000000000563.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share